Austerity measures following the global recession have created inequities in access to drugs with concern about the impact on subsequent outcomes. The aim was to identify their attitudes towards current cancer research and challenges faced when reporting science news.
The media purport to provide information that is focused, relevant, and easily understandable, enabling the wider public to identify applicable risk factors and adopt healthy lifestyles and choices, as well as promote research into cancer directly benefiting charitable funders.
Similar findings have been noted in other studies, with bladder cancer frequently under-represented, and breast cancer dominating coverage about specific cancer sites across all media formats [ 15 — 17 ]. These debates are becoming increasingly complex, even as we face stagnating health budgets.
Methods Between June and Septembera survey was carried out as part of the broader Eurocancercomms program looking at cancer communication across Europe. DCIS accounts for up to 25 percent of breast cancers.
Under a Creative Commons license open access Abstract In high-income countries the public policy consensus is that costs of delivering high-quality equitable cancer care present an increasing challenge to national budgets. If DCIS shows little or no growth, patients can avoid more aggressive treatment.
She encourages patients with DCIS to consider participating in clinical trials and registries to review their options. In this qualitative study, we sought to understand the interaction between the media and cancer through the perspective of European science journalists by defining their attitudes towards current cancer research and challenges faced when reporting science news.
This article has been cited by other articles in PMC. Previous article in issue. Key areas include a more precise definition of the research context and differentiation of absolute and relative risks, as well as individual and population risks and an informed discussion about the realities and limitations of cancer care and research.
The cancer economics debate has largely centred on the provision of drugs, with access to radiotherapy and over-penetration of high cost radiation technologies under-represented in media outputs and political discussion.
The increase is being driven by a number of factors including technological innovation, rising costs of medical and hospital care, expensive therapeutics and an increase in the proportion of individuals susceptible to malignancy as the population ages.
Respondents were involved in a range of media outputs, with nearly two-third of subjects working for magazines or online news services.
A recent study reviewing media coverage of medical research found that newspapers were more likely to cover observational studies than randomised control trials and preferentially cover research with weaker methodology [ 1011 ].
Abstract The media plays a vital role in informing the public about new developments in cancer research and influencing cancer policy. Respondents were conscious of being fed ambiguous and exaggerated results from trials by the research community.
In this article we review what factors are informing and influencing the political debate on cancer economics across Europe and North America. Laura Esserman at the University of California, San Francisco, is considered a pioneer of "active surveillance" or "watchful waiting" treatment for breast cancer.
This tends to mirror the degree of celebrity endorsement and corporate sponsorship [ 151819 ]. An important theme is the increasing role of individual patients, organisations and physicians in advocating for greater access to and fairer prices for cancer therapies.
Much of this information has been ambivalent, conflicting, and scientifically questionable, resulting in a public frenzy about cancer [ 5 — 7 ].The debate over early breast cancer treatment invasive form of the disease is being over-diagnosed and over-treated.
of medicine and breast cancer is not just to do more for those who need Founded: Sep 18, The study sought to determine the role of health education on breast cancer awareness among University of health campaign awareness, mass media, seminars, workshops, school - Health education has no significant role in reducing breast cancer.
Cancer economics, policy and politics: What informs the debate? We must also be aware of the key factors that play a significant role in cancer policy aside from economics including socio-cultural values, advocacy and political influence at the country and regional level.
However there remains significant debate as to whether this. Dr. Anas Younes explores the recent debate over columns published in The New York Times and The Guardian and discusses how both doctors and patients use social media to talk about cancer.
The media plays a vital role in informing the public about new developments in cancer research and influencing cancer policy. This is no easy task, in view of the myriad of trials and wonder drugs that purport to be the ‘magic bullet’.
However, misrepresentation can have profound consequences. Soc 1 - Inquizitive Chapter 4 STUDY.
PLAY. - You feel sadness for your friend who has just lost her mother to cancer (empathetic role-taking) An example of this is when - have an effect on whether or not a gene expresses itself. environmental contexts.Download